NEWS RELEASE - For Immediate Release

Celsense, Inc. Announces First Product Sales

July 22, 2007 - Pittsburgh, Pennsylvania

Celsense, Inc, a provider of reagents and methods for imaging transplanted cells in vivo, announced that it had delivered initial quantities of Cell Sense to customers in the US and Europe. Cell Sense, an MRI tracer agent, is the company’s lead product for non-invasively imaging transplanted cells in vivo.
"This is a big step toward our goal of delivering this important new capability to the market. We are fortunate to be collaborating with industry leaders to solve their challenging imaging problems,” said Charlie O’Hanlon, President and CEO.

About Celsense, Inc. – Celsense is a Pittsburgh-based biotechnology company offering products that enable the real-time in vivo imaging of transplanted cells for therapeutic and diagnostic purposes. The mission of the company is to be the imaging standard for transplanted cells in human health.

Contact Information:

Charlie O’Hanlon, President and CEO
Celsense, Inc.